{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T20:15:27Z","timestamp":1788034527388,"version":"build-2784847793"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.encep.2026.06.002","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T19:18:13Z","timestamp":1788031093000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prucalopride repurposing: 5-HT4 receptor agonists in anxiety and depression"],"prefix":"10.1016","author":[{"given":"Salma R.","family":"Abdennebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Rodriguez-Lua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Bottemanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Corruble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis J.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Mendez-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2026.06.002_bib0105","doi-asserted-by":"crossref","unstructured":"GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry 2022;9(2):137\u2013150. doi:10.1016\/S2215-0366(21)00395-3. [PubMed PMID: 35026139].","DOI":"10.1016\/S2215-0366(21)00395-3"},{"issue":"7","key":"10.1016\/j.encep.2026.06.002_bib0110","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1017\/S0033291720000604","article-title":"Translating the promise of 5HT4 receptor agonists for the treatment of depression","volume":"51","author":"Murphy","year":"2021","journal-title":"Psychol Med"},{"issue":"1","key":"10.1016\/j.encep.2026.06.002_bib0115","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12916-020-01738-z","article-title":"Comorbidity between depression and anxiety: assessing the role of bridge mental states in dynamic psychological networks","volume":"18","author":"Groen","year":"2020","journal-title":"BMC Med"},{"issue":"8","key":"10.1016\/j.encep.2026.06.002_bib0120","doi-asserted-by":"crossref","first-page":"e0330277","DOI":"10.1371\/journal.pone.0330277","article-title":"Long-term neurological consequences following benzodiazepine exposure: a scoping review","volume":"20","author":"Shade","year":"2025","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.encep.2026.06.002_bib0125","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.3390\/ijms19113581","article-title":"Alterations of expression of the serotonin 5-HT4 receptor in brain disorders","volume":"19","author":"Rebholz","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.encep.2026.06.002_bib0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuropharm.2016.08.037","article-title":"The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor","volume":"111","author":"Amig\u00f3","year":"2016","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.encep.2026.06.002_bib0135","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamapsychiatry.2022.4539","article-title":"Serotonin 4 receptor brain binding in major depressive disorder and association with memory dysfunction","volume":"80","author":"K\u00f6hler-Forsberg","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2026.06.002_bib0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2982.2007.01059.x","article-title":"5-HT4 receptor agonists: similar but not the same","volume":"20","author":"De Maeyer","year":"2008","journal-title":"Neurogastroenterol Motil"},{"issue":"23","key":"10.1016\/j.encep.2026.06.002_bib0145","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.2174\/13816128113196660734","article-title":"Serotonin 5-HT4 receptors: a new strategy for developing fast acting antidepressants?","volume":"20","author":"Vidal","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.encep.2026.06.002_bib0150","first-page":"49","article-title":"Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation","volume":"3","author":"Wong","year":"2010","journal-title":"Clin Exp Gastroenterol"},{"issue":"1","key":"10.1016\/j.encep.2026.06.002_bib0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41522-026-00928-6","article-title":"Prucalopride, a serotonin type 4 receptor agonist, induces fast anxiolytic\/antidepressant effects and concomitant changes in the gut microbiota","volume":"12","author":"Cussotto","year":"2026","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.encep.2026.06.002_bib0195","doi-asserted-by":"crossref","first-page":"859123","DOI":"10.3389\/fpsyt.2022.859123","article-title":"The effect of the 5-HT4 agonist, prucalopride, on a functional magnetic resonance imaging faces task in the healthy human brain","volume":"13","author":"de Cates","year":"2022","journal-title":"Front Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2026.06.002_bib0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1192\/bjp.2024.97","article-title":"Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial","volume":"225","author":"de Cates","year":"2024","journal-title":"Br J Psychiatry"},{"issue":"5","key":"10.1016\/j.encep.2026.06.002_bib0165","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.neuron.2007.07.041","article-title":"Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action","volume":"55","author":"Lucas","year":"2007","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.encep.2026.06.002_bib0160","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/npp.2013.332","article-title":"Rapid anxiolytic effects of a 5-HT4 receptor agonist are mediated by a neurogenesis-independent mechanism","volume":"39","author":"Mendez-David","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.encep.2026.06.002_bib0175","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41386-019-0540-3","article-title":"Prophylactic efficacy of 5-HT4R agonists against stress","volume":"45","author":"Chen","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.encep.2026.06.002_bib0180","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbr.2012.02.012","article-title":"Synergistic effect of acetylcholinesterase inhibition (donepezil) and 5-HT(4) receptor activation (RS67333) on object recognition in mice","volume":"230","author":"Freret","year":"2012","journal-title":"Behav Brain Res"},{"issue":"6","key":"10.1016\/j.encep.2026.06.002_bib0155","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.biopsych.2019.08.009","article-title":"Rapid anxiolytic effects of RS67333, a serotonin type 4 receptor agonist, and diazepam, a benzodiazepine, are mediated by projections from the prefrontal cortex to the dorsal raphe nucleus","volume":"87","author":"Faye","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.encep.2026.06.002_bib0185","doi-asserted-by":"crossref","first-page":"110810","DOI":"10.1016\/j.neuropharm.2025.110810","article-title":"Activation of 5-HT4 receptors reverses stress-induced dopamine system dysregulation","volume":"285","author":"Yang","year":"2026","journal-title":"Neuropharmacology"},{"issue":"16","key":"10.1016\/j.encep.2026.06.002_bib0190","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1017\/S0033291719002836","article-title":"A role for 5-HT4 receptors in human learning and memory","volume":"50","author":"Murphy","year":"2020","journal-title":"Psychol Med"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700626001594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700626001594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T19:18:16Z","timestamp":1788031096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700626001594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"alternative-id":["S0013700626001594"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2026.06.002","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prucalopride repurposing: 5-HT4 receptor agonists in anxiety and depression","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2026.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}